Medicines Co (MDCO) Reports Q2 Adj-EPS of 46c

Medicines Co (NASDAQ: MDCO) reported Q2 adj-EPS of $0.46, GAAP EPS were $0.25, vs. the analyst estimate of $0.17. Revenue for the quarter came in at $135.7 million versus the consensus estimate of $131.78 million.

For earnings history and earnings-related data on Medicines Co (MDCO) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat